Anakinra for the Prevention of Cytokine Release Syndrome and Neurotoxicity in Patients With B-Cell Non-Hodgkin Lymphoma Receiving CD19-Targeted CAR-T Cell Therapy
Clinical trial NCT04359784 · COMPLETED
Trial details
- NCT number
- NCT04359784
- Sponsor
- Fred Hutchinson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-27
- Primary completion
- 2024-10-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.